Atlas Trials

Glioblastoma, IDH-wildtype

36 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Glioblastoma, IDH-wildtype

RecordFirmDate
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (NCT06095375)Istituto Oncologico Veneto IRCCS2022-07-04
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM (NCT05271240)Northwell Health2022-04-27
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201) (NCT06118723)Jasper Gerritsen2022-01-01
BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels (NCT05375318)Juan M Garcia-Gomez2021-03-01
Biomolecular Analysis for Predicting Response to Regorafenib (NCT05759195)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2021-01-07
Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma (NCT04528680)Northwestern University2020-10-29
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262)St. Jude Children's Research Hospital2018-03-05

Track Glioblastoma, IDH-wildtype automatically

Every clearance here is in the API, with alerts when new ones post.